OmniSeq Email Format

Biotechnology ResearchNew York, United States51-200 Employees

OmniSeq, an innovation of Roswell Park Cancer Institute, is a molecular diagnostic laboratory based in Buffalo, New York. OmniSeq endeavors to find the right drug or the right trial for every patient by improving access to better cancer treatment options through molecular profiling.  

In addition to other NY State CLEP approved assays, OmniSeq offers OmniSeq Comprehensive and Immune Report Card.  These two assays are available clinically in the United States and interrogate all known genomic and immune markers tied to approved therapeutics and clinical trials.  OmniSeq is also making significant investments to create better diagnostics for immuno-oncology therapy selection.  OmniSeq is proud to partner with pharmaceutical companies to provide research support for immuno-oncology development projects.  

For more information, call 1-800-781-1259 or visit www.omniseq.com.

✕

Access Insights for OmniSeq and Millions of Other Companies

Sign up for full access to OmniSeq information.

Continue with GoogleContinue with Microsoft

No credit card needed

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory